(30 days)
The VascuView TAP Ultrasound System with probe Model #HL.7.5/40/64D is intended for diagnostic imaging of the human body for the following clinical applications, as illustrated in the Diagnostic Indications for Use Form which can be found in Attachment 5A: Pediatric, Musculo-skeletal (Conventional), Musculo-skeletal (Superficial), Peripheral Vessels which include Intra-Venous and Perioherally-Inserted Central Catheters, as well as vascular structures and surrounding vascular regions such as nerve bundles and various structures for free hand placement of needles/catheters. The VascuView TAP Ultrasound System is not intended for fetal or ophthalmic applications.
The VascuView TAP Ultrasound System is a high-frequency ultrasonic imaging system intended to be used for assisted vascular access of veins and arteries, in addition to other vascular access applications such as the real-time viewing of perigheral vascular structures and their surrounding regions in order to provide quidance for the placement of needles and catheters within these structures. The system software runs on Windows XP Professional Operating System and utilizes features of the Windows interface to direct the operation of the system and maintain patient records; providing a user-friendly environment for clinical applications. The VascuView TAP System consists of the following components:
- UL and TUV 60950 Approved Tablet PC with Integrated Outer Enclosure . A Kiosk tablet oc is provided with a UL approved Medical-grade power supply and Medical-grade power cord. The VascuView TAP ultrasound system consists of an integrated carrying handle. probe holder, cord wrap, table stand, and shock absorbent corner bumpers. The pc includes a large 12.1" TFT XGA LCD wide angle display which facilitates an intuitive touch screen control interface with clear-cut functionality and preset settings to ameliorate image optimization. Additionally, the oc provides for the operation of the software, as well as the storage of archived images and video clips.
- . Ultrasound Beam-former PCB with 64-element Linear Array Probe The handheld ultrasound probe Model #HL7.5/40/64D and beam-former PCB consists of a sixtyfour element pulsed linear array capable of capturing both images and videos in four different modes of operation: B-Mode, Split Screen Dual B-Mode, Color Doppler (CFM), and B-Mode with Doppler (PWD). The probe is connected to the pc via the included SCSI cable and operates within a frequency range of 5MHz -- 10MHz, which allows for the visualization of surface vessels at scan depths up to 9cm. The transducer material is made of a gold plated polymer membrane and a biocompatible nose cone sufficient for its use (Silicon).
- . VascuView TAP System Software
All features and controls of the system are provided for in the VascuView TAP software which comes pre-loaded onto the tablet pc. The software uses an icon-based interface whereby the user can select any of the primary functional screens at any time by clicking on an icon located on the screen, for that function. The software enables ultrasound image storage and display, measurement functions, enhancements, and printing. All parameters within the hard-coding of the VascuView TAP software program are fixed, therefore the user cannot make any adjustments to the operation of the transducer that will have an effect on the radiated field (i.e. center frequency, aperture, focus, field of view, sample rate, etc.)
Here's an analysis of the provided text regarding the VascuView TAP Ultrasound System, focusing on acceptance criteria and the study proving its performance.
Overview:
The provided document is a 510(k) summary for the VascuView TAP Ultrasound System. It primarily focuses on demonstrating substantial equivalence to predicate devices (SONOACE PICO and SonoSite® iLook 25) rather than presenting a novel clinical study with new acceptance criteria. The performance data discussed is non-clinical for safety and measurement accuracy, and no clinical performance data was submitted. Therefore, many of the requested sections about clinical study design (sample size, experts, ground truth, MRMC, standalone performance, training set) will not be applicable or directly addressed in this document.
1. Table of Acceptance Criteria and Reported Device Performance
Since this is a 510(k) submission based on substantial equivalence, the "acceptance criteria" are primarily regulatory compliance and demonstration of similar technical characteristics and performance to predicate devices. There are no explicit clinical performance metrics (e.g., sensitivity, specificity) with associated acceptance thresholds provided as would be typical for a de novo device or a device claiming superior performance.
| Acceptance Criteria (Implied from 510(k) process) | Reported Device Performance |
|---|---|
| Regulatory Compliance & Safety: | |
| Compliance with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-4, IEC 60601-2-37 (including acoustic output limits), etc. | Verified as compliant with these standards (including acoustic output limits). |
| Compliance with EN 61000-3-2, EN 61000-3-3, EN 55011 | Verified as compliant with these standards. |
| Compliance with CISPR 11 | Verified as compliant with this standard. |
| Compliance with ISO 14971, ISO 13485, ISO 10993-1, ISO 10993-5, ISO 10993-10, ISO 10993-11 | Verified as compliant with these standards. |
| Functional/Technical Performance (Comparison to Predicates): | |
| Equivalent Diagnostic Imaging Capabilities (modes, applications) | - Supports B-Mode, Split Screen Dual B-Mode, Color Doppler (CFM), and B-Mode with Doppler (PWD).- Intended for Pediatric, Musculo-skeletal (Conventional), Musculo-skeletal (Superficial), Peripheral Vessels (including IV and PICC), and guidance for needle/catheter placement.- Similar clinical applications to predicate devices.- Probe: 64-element linear array, 5MHz-10MHz frequency range, scan depths up to 9cm. |
| Equivalent Measurement Accuracy | Measurement accuracy confirmed via a measurement validation test protocol using an ATS model 539 phantom with 0.7 dB/cm-MHz attenuation. (Specific accuracy metrics are not provided in this summary but the test was performed). |
| Software Validation | Software validated using a test protocol. (Details of validation metrics are not provided in this summary). |
| Overall Safety and Effectiveness | "the VascuView TAP system has demonstrated that it is as safe, as effective, performs as well as or better than the predicate devices, and includes similar design characteristics and intended use. Furthermore, based on the comparison with the predicate devices... the Escalon Vascular Access VascuView TAP ultrasound system is deemed to be substantially equivalent to the proposed predicate devices." (Conclusion based on non-clinical data and comparison, not new clinical trial data). |
2. Sample Size Used for the Test Set and the Data Provenance
- Sample Size: Not applicable for a clinical test set, as no clinical performance data was submitted.
- Data Provenance: The document only mentions "Non-Clinical Performance Data" and "Measurement Accuracy Validation Report" using an "ATS model 539 phantom." This indicates engineered phantom data rather than patient data.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts
Not applicable. No clinical ground truth was established from experts for this 510(k) submission, as no clinical performance data was submitted. The non-clinical measurement accuracy used a phantom as ground truth.
4. Adjudication Method for the Test Set
Not applicable. No clinical adjudication method was used, as no clinical performance data was submitted.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance
Not applicable. No MRMC study was conducted or reported. This device is an ultrasound system intended for direct use by clinicians, not an AI-assisted diagnostic tool for image interpretation by readers.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Not applicable. This is an ultrasound imaging system, not an AI algorithm. Its "performance" involves generating images for human interpretation and use in vascular access guidance.
7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)
For the non-clinical performance data:
- The ground truth for measurement accuracy was an "ATS model 539 phantom with 0.7 dB/cm-MHz attenuation." This is a controlled, engineered standard for ultrasound measurement.
- The "software has been also been validated using a test protocol," suggesting internal testing against expected software functionality, but specific ground truth types are not detailed.
8. The Sample Size for the Training Set
Not applicable. The device is an ultrasound imaging system, not a machine learning model that requires a training set in the conventional sense. Software validation would involve testing against requirements, but not "training data."
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set for an AI model. For the non-clinical validation, the "ground truth" for measurement accuracy was inherent in the phantom used.
{0}------------------------------------------------
K09 3da3
2440 South 179th Street New Berlin, WI 53146 Tel 800-433-8197 Fax 262-821-9927 www.escalonvascularaccess.com
Image /page/0/Picture/3 description: The image is a logo for Escalon Vascular Access, a division of Escalon Medical Corp. The logo features a stylized "VA" with a catheter running through it horizontally. To the right of the "VA" is a symbol resembling radio waves or a signal, possibly representing access or communication.
Summary of Safety and Effectiveness Information
This summary of 510(k) safety and effectiveness for the VascuView TAP™ Ultrasound System is being submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990 and the Premarket Notification Procedures of 21 CFR; Part 807, Subpart E, Section 807.92 upon which the substantial equivalence (SE) determination is based.
| Submitter's Name | Escalon Medical Corp2440 South 179th StreetNew Berlin, WI 53146800-433-8197 262-821-9182Fax 262-821-9927 |
|---|---|
| Contact Person | Roger EdensVice-President EngineeringTel: (262) 821-9182Fax: (262) 821-9927reddens@escalonmed.com |
| Date of Preparation | October 13, 2009 |
| Device Trade Name | VascuView TAP™ Ultrasound System |
| Common Name(s) | Ultrasonic Pulsed Echo Imaging SystemDiagnostic Ultrasound Transducer |
| Classification Name(s) | Ultrasonic Pulsed Echo Imaging SystemFR Number: 892.1560Product Code: 90-IYO |
| Diagnostic Ultrasound TransducerFR Number: 892-1570Product Code: 90-ITX | |
| Ultrasonic Pulsed Doppler Imaging SystemFR Number: 892-1550Product Code: 90-IYN | |
| Device Classification | Class II |
| Predicate Device(s) | SONOACE PICO Diagnostic Ultrasound System510(k) Number: K061213SE Clearance Date: May 16, 2006 |
| Sonosite iLook 25 Personal Imaging Tool510(k) Number: K033367SE Clearance Date: November 5, 2003 |
DEC 2 3 2009
{1}------------------------------------------------
VascuView TAP Device Description
The VascuView TAP Ultrasound System is a high-frequency ultrasonic imaging system intended to be used for assisted vascular access of veins and arteries, in addition to other vascular access applications such as the real-time viewing of perigheral vascular structures and their surrounding regions in order to provide quidance for the placement of needles and catheters within these structures. The system software runs on Windows XP Professional Operating System and utilizes features of the Windows interface to direct the operation of the system and maintain patient records; providing a user-friendly environment for clinical applications. The VascuView TAP System consists of the following components:
- UL and TUV 60950 Approved Tablet PC with Integrated Outer Enclosure . A Kiosk tablet oc is provided with a UL approved Medical-grade power supply and Medical-grade power cord. The VascuView TAP ultrasound system consists of an integrated carrying handle. probe holder, cord wrap, table stand, and shock absorbent corner bumpers. The pc includes a large 12.1" TFT XGA LCD wide angle display which facilitates an intuitive touch screen control interface with clear-cut functionality and preset settings to ameliorate image optimization. Additionally, the oc provides for the operation of the software, as well as the storage of archived images and video clips.
- . Ultrasound Beam-former PCB with 64-element Linear Array Probe The handheld ultrasound probe Model #HL7.5/40/64D and beam-former PCB consists of a sixtyfour element pulsed linear array capable of capturing both images and videos in four different modes of operation: B-Mode, Split Screen Dual B-Mode, Color Doppler (CFM), and B-Mode with Doppler (PWD). The probe is connected to the pc via the included SCSI cable and operates within a frequency range of 5MHz -- 10MHz, which allows for the visualization of surface vessels at scan depths up to 9cm. The transducer material is made of a gold plated polymer membrane and a biocompatible nose cone sufficient for its use (Silicon).
- . VascuView TAP System Software
All features and controls of the system are provided for in the VascuView TAP software which comes pre-loaded onto the tablet pc. The software uses an icon-based interface whereby the user can select any of the primary functional screens at any time by clicking on an icon located on the screen, for that function. The software enables ultrasound image storage and display, measurement functions, enhancements, and printing. All parameters within the hard-coding of the VascuView TAP software program are fixed, therefore the user cannot make any adjustments to the operation of the transducer that will have an effect on the radiated field (i.e. center frequency, aperture, focus, field of view, sample rate, etc.)
The VascuView TAP Ultrasound System has been designed, as applicable to its features, to comply with the following product safety standards listed in the table below.
| IECStandard | IEC 60601-1:2005 Medical Electrical Equipment: Part 1 - General Requirements for Safety IEC 60601-1-1:2000 Medical Electrical Equipment Collateral Standard: Safety Requirements for MedicalElectrical Systems IEC 60601-1-2:2001 Medical Electrical Equipment Collateral Standard: Electromagnetic Compatibility IEC 60601-1-4:1996 Medical Electrical Equipment Collateral Standard: Part 4: Safety Requirements forProgrammable Electronic Medical Systems IEC 60601-2-37:2004 Medical Electrical Equipment: Part 2 - Particular Requirements for the Safety ofUltrasonic Medical Diagnostic and Monitoring |
|---|---|
| ENStandard | EN 61000-3-2:2000 Limits for Harmonic Current Emissions EN 61000-3-3:1995 Electromagnetic Compatibility: Limitation of Voltage Fluctuation and Flicker in Low-Voltage Supply Systems with Rated Current Up to 16 Amps EN 55011: 1998 (A1:1999) Group 1, Class A for Industrial, Scientific, and Medical (ISM) Equipment |
| CISPRStandard | CISPR 11:2004 Group 1, Class A, for Industrial, Scientific, and Medical (ISM) Equipment: RadioFrequency Equipment Electromagnetic Disturbance Characteristics Limits and Methods of Measurement |
| ISOStandard | ISO 14971:2007 Medical Devices - Applications of Risk Management to Medical Devices ISO 13485:2003 Medical Devices Quality Management Systems - Requirements for Regulatory Purposes ISO 10993-1:2009 Biological Evaluation of Medical Devices Part 1 -- Evaluation and Testing within a RiskManagement Process ISO 10993-5:2009 Biological Evaluation of Medical Devices: Part 5 - Tests for In Vitro Cytoxicity ISO 10993-10:2002 Biological Evaluation of Medical Devices: Part 10 - Tests for Irritation and Delayed-Type Hypersensitivity ISO 10993-11:2006 Biological Evaluation of Medical Devices: Part 11 - Tests for Systemic Toxicity |
{2}------------------------------------------------
Intended Use / Indications for Use
The VascuView TAP Ultrasound System with probe Model #HL.7.5/40/64D is intended for diagnostic imaging of the human body for the following clinical applications, as illustrated in the Diagnostic Indications for Use Form which can be found in Attachment 5A: Pediatric, Musculo-skeletal (Conventional), Musculo-skeletal (Superficial), Peripheral Vessels which include Intra-Venous and Perioherally-Inserted Central Catheters, as well as vascular structures and surrounding vascular regions such as nerve bundles and various structures for free hand placement of needles/catheters. The VascuView TAP Ultrasound System is not intended for fetal or ophthalmic applications.
Device Technology Characteristics and Comparison to Predicate Device(s)
The legally marketed predicate device(s) to which the VascuView TAP Ultrasound System is considered substantially equivalent through the 510(k) premarket notification process are the SONOACE PICO Diagnostic Ultrasound System cleared under K061213 and the SonoSite® iLook 25 Ultrasound System cleared under K033367.
Based on the Comparison with Predicate Devices as shown in the table illustrated in Section 6 of this 510(k) submission, as per the guidance of FDA Substantial Equivalence recommendations, the VascuView TAP Ultrasound System is deemed sufficient in the demonstration of substantial equivalence to both predicate devices. A summarization of the similarities and differences between the VascuView TAP and each of the proposed predicate devices is discussed below.
| Proprietary Device Name | SONOACE PICO Diagnostic Ultrasound System | SonoSite® iLook 25 Ultrasound System |
|---|---|---|
| Trade Name | SONOACE PICO Ultrasound System | iLook 25 Ultrasound System |
| 510(k) Submitter/Holder | Medison, Co., Ltd. | SonoSite, Inc. |
| 510(k) Number | K061213 | K03367 |
| Regulatory Class | Class II | Class II |
| Regulation Number | 21 CFR 892.1550 | 21 CFR 892.1550 |
| Classification Product Code | IYN | IYN |
Summary for explanation of the Predicate Device(s) Technological Characteristics
Similarities of the SONOACE PICO and the VascuView TAP include:
- . Both systems are intended for Pediatric, Vascular, and Musculoskeletal applications.
- Both systems are mobile, software-controlled systems whose function is to acquire ultrasound . data and to display the data in different imaging modes.
- Both systems are capable of displaying images in the following modes of operation: 2D B-Mode, . Color Doppler (CFM), and B-Mode with Doppler (PWD).
- Both systems possess linear measurement capabilities. .
- Both systems include a 64-element linear array probe design operating within a frequency range . of 5MHz - 10MHz.
- Both systems have an LCD display .
- . Both systems include Cine review capabilities.
- Both systems transmit ultrasonic energy into patients. then perform post-processing of received . echoes to generate on-screen display of anatomic structures within the body.
- . Both systems allow for specialized measurements of structures.
- . Both systems provide for on-screen display of thermal and mechanical indices related to potential bio-effect mechanisms
Differences of the SONOACE PICO and the VascuView TAP include:
- . The SONOACE PICO is a dedicated device, while the VascuView TAP system utilizes a tablet pc set up to launch immediately into the VascuView TAP software.
- The VascuView TAP provides for a larger screen to aid in visualization. .
- The SQNOACE PICO offers M-Mode Imaging, Tissue Harmonic Imaging, Trapezoidal Imaging, . and freehand 3D imaging tools of which are not provided for in the Vascuview TAP.
- The SONOACE PICO indications for use includes: fetal applications, whereas the VascuView . TAP is not.
{3}------------------------------------------------
Similarities of the SonoSite® iLook 25 Ultrasound System and the VascuView TAP include:
- Both systems are intended for Pediatric, Vascular, and Musculoskeletal (both conventional and . superficial), and Peripheral Vessel applications.
- . Both systems are highly portable, software-controlled systems whose function is to acquire ultrasound data and to display the data in different imaging modes.
- Both systems are capable of displaying images in the following modes of operation: 2D B-Mode, . and Color Doppier (CFM) Mode.
- . Both systems possess linear measurement capabilities which incorporate a linear array probe and beamformer (pulser and receiver) circuitry.
- . Both systems provide controls for touch screen data input, menu, freeze, patient information, save and power.
- . Both systems provide a power Doppler mode that displays different colors (red or blue) by determining directionality of blood flow within vessels which, given the anatomical location of the vessel and orientation of the ultrasound probe.
- . Both systems assist the user in determining whether a vessel is a vein or artery by allowing for the observation of whether the vessel is pulsing (indicating an artery) or not (indicating a vein), in addition to anatomical location.
- Both systems include Cine review to retain images for frame-by-frame viewing. .
- Both systems provide for system optimization presets and a crystal display with brightness and . contrast controls.
Differences of the SonoSite® iLook 25 Ultrasound System and the VascuView TAP include:
- The SonoSite® iLook 25 is a dedicated device, while the VascuView TAP system utilizes a tablet . pc set up to launch immediately into the VascuView TAP software.
- . The VascuView TAP provides for a larger screen to aid in visualization; approximately 4x greater in viewing area.
- . The SonoSite® iLook 25 is limited to an internal storage capacity of 74 images, while the VascuView TAP system has virtually unlimited storage (tens of thousands of images on tablet pc hard drive and ability to connect external hard drives if additional storage is required).
- The SonoSite® iLook 25 indications for use includes: fetal applications, whereas the VascuView . TAP is not.
Non-Clinical Performance Data
The VascuView TAP will be assessed as verified as compliant with the requirements of several international safety standards, including IEC 60601-1, IEC 60601-1-2, IEC 60601-1-4, and IEC 60601-2-37 (including acoustic output limits), and others. Additionally, the measurement accuracy of the VascuView TAP system was confirmed via a measurement validation test protocol (Attachment 8A Measurement Accuracy Validation Report) using an ATS model 539 phantom with 0.7 dB/cm-MHz attenuation. The software has been also been validated using a test protocol.
Clinical Performance Data
None submitted.
Conclusions from Non-Clinical (and Clinical) Data
Based upon the results of the data as summarized above, the VascuView TAP system has demonstrated that it is as safe, as effective, performs as well as or better than the predicate devices, and includes similar design characteristics and intended use. Furthermore, based on the comparison with the predicate devices as shown in the discussion above, as well as guidance provided by FDA 510(k) Substantial Equivalence Decision-Making Process Flowchart, the Escalon Vascular Access VascuView TAP ultrasound system is deemed to be substantially equivalent to the proposed predicate devices.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle-like symbol with three lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the symbol.
DEC 2 3 2009
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
: '
Escalon Medical Corporation % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313
Re: K093613
Trade/Device Name: VU65000 - VascuView TAP Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, and ITX Dated: December 16, 2009 Received: December 17, 2009
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the VU65000 - VascuView TAP Ultrasound System, as described in your premarket notification:
Transducer Model Number
HL7.5/40/64D
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{5}------------------------------------------------
Page 2 - Mr. Job
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
If you have any questions regarding the content of this letter, please contact Shahram Vaezy at (301) 796-6242.
Sincerely vours.
Joha C. Myri
for
Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
{6}------------------------------------------------
Indications for Use
510(k) Number (if known):
K0936/3
Device Name:
Indications For Use:
VascuView TAP Ultrasound System
The VascuView TAP ultrasound system provides ultrasound imaging of peripheral vascular structures in order to provide for ultrasound guidance for placement of needles and catheters in these structures. The VascuView TAP is also used for ultrasound imaging of vascular structures and surrounding regions of the vascular such as nerve bundles and various structures.
The VascuView TAP ultrasound system is not intended for fetal or ophthalmic applications.
× Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21. CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
_
(Division Sign-Off)_
Division of Reproductive, Abdominal. and Radiological Devices 510(k) Number.
Page 1 of
{7}------------------------------------------------
Appendix G
Appendix G: Diagnostic Ultrasound Indications For Use Form
VU65000 - Vascu/iew TAP Ultrasound System System:
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Modes of Operations | |||||||
|---|---|---|---|---|---|---|---|---|
| Specific(Tracks 1 & 3) | B | M | PWD | CWD | ColorDoppler | Combined(Specify) | Other*(Specify) | |
| General(Track 1 Only) | Opthalmic | |||||||
| Opthalmic | Fetal | |||||||
| Abdominal | ||||||||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | N | N | N | Note [1] | ||||
| Small Organ (Specify) | ||||||||
| Neonatal Cephalic | ||||||||
| FetalImaging& Other | Adult Cephalic | |||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skeletal(Conventional) | N | N | N | Note [1] | ||||
| Musculo-skeletal(Superficial) | N | N | N | Note [1] | ||||
| Intravascular | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adult | |||||||
| Cardiac Pediatric | ||||||||
| Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Intra-cardiac | ||||||||
| Other (Specify) | ||||||||
| PeripheralVessel | Peripheral Vessel Note [2] | N | N | N | Note [1] | |||
| Other (Specify) Note [3] | N | N | N | Note [1] |
N = new indication; P = previously cleared by FDA; E = added under this appendix
*Example of other modes of operation may include: A-mode, Amplitude Doppler, 3-D Imaging, Harmonic Imaging, Tissue Motion Doppler, and Color Velocity Imaging for prescription use.
Notes:
- [1] B+PW, B+Color Doppler
- [2] Includes Intra-Venous, Peripherally-Inserted Central Catheters
- [3] Imaging of vascular structures and surrounding regions of the yascular such as nerve bundles and various structures for free hand placement of needles/catheters.
Nommhing
(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Device
510(k) Number K0436
{8}------------------------------------------------
Appendix G
Appendix G: Diagnostic Ultrasound Indications For Use Form
VU65000 - VascuView TAP Ultrasound System System: Probe Model #HL7 5/40/64D Transducer:
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Modes of Operations | |||||||
|---|---|---|---|---|---|---|---|---|
| General(Track 1 Only) | Specific(Tracks 1 & 3) | B | M | PWD | CWD | Color Doppler | Combined (Specify) | Other* (Specify) |
| Opthalmic | Opthalmic | |||||||
| Fetal | ||||||||
| Abdominal | ||||||||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | N | N | N | N | Note [1] | |||
| Small Organ (Specify) | ||||||||
| Neonatal Cephalic | ||||||||
| FetalImaging& Other | Adult Cephalic | |||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skeletal(Conventional) | N | N | N | N | Note [1] | |||
| Musculo-skeletal(Superficial) | N | N | N | N | Note [1] | |||
| Intravascular | ||||||||
| Other (Specify) | ||||||||
| Cardiac Adult | ||||||||
| Cardiac | Cardiac Pediatric | |||||||
| Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Intra-cardiac | ||||||||
| Other (Specify) | ||||||||
| PeripheralVessel | Peripheral Vessel Note [2] | N | N | N | N | Note [1] | ||
| Other (Specify) Note [3] | N | N | N | N | Note [1] |
N = new indication; P = previously cleared by FDA; E = added under this appendix
*Example of other modes of operation may include: A-mode, Amplitude Doppler, 3-D Imaging, Harmonic Imaging, Tissue Motion Doppler, and Color Velocity Imaging for prescription use.
Notes:
- [1] B+PW. B+Color Doppler
- [2] Includes Intra-Venous, Peripherally-Inserted Central Catheters
- [3] Imaging of vascular structures and surrounding regions of the vascular such as nerve bundles and various structures for free hand placement of needles/catheters.
Norm Whing
(Division Sign-Off)
Division of Reproductive, Abdominal. and Radiological Devi
510(k) Number K0936
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.